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INTRODUCTION
Although pediatric cardiac critical care, as a distinct field of
interest, is a relatively recent development, treating critically
ill patients has always been a substantial part of clinical
pediatric cardiology. In addition, even pediatric cardiol-
ogists who do not provide primary care for critically ill
patients will be asked to consult on such patients. It
therefore seems appropriate to specify what knowledge and
skills relevant to the care of critically ill patients should be
taught in a pediatric cardiology fellowship program.
FACILITIES AND ENVIRONMENT
Not all pediatric cardiac training programs have a separate
pediatric cardiac intensive care unit (ICU), and in some
training programs the primary care of hemodynamically
compromised cardiac patients is provided by physicians
other than pediatric cardiologists. However, this should not
preclude trainees from attaining the specified requirements
through interaction with pediatric cardiologists, pediatric
intensivists, neonatologists, pediatric cardiac surgeons, and
other practitioners. Because the advanced practitioner must
be board eligible or board certified in pediatric cardiology, it
is implied that the pediatric cardiology training be done in
an Accreditation Council for Graduate Medical Education
(ACGME)-approved training program. The additional
nine months of advanced training specified below should
take place in an institution in which at least 250 pediatric
cardiac procedures per year (this number is by consensus of
the authors), utilizing cardiopulmonary bypass, are per-
formed.
LEVELS OF EXPERTISE
In formulating the core training requirements, it was ex-
pected that all board-certified pediatric cardiologists should
be proficient in the following: 1) the evaluation and (at least)
initial stabilization of the hemodynamically compromised
pediatric patient with heart disease; and 2) consultation with
surgeons, pediatric intensivists, neonatologists, and others
regarding the medical, and preoperative and postoperative
management of pediatric patients with heart disease.
It is unrealistic to expect all pediatric cardiac trainees to
be expert (and stay expert) in the most advanced aspects of
pediatric cardiac critical care. In many centers the critical
care management of pediatric cardiac patients is provided
primarily by pediatric intensivists, neonatologists, or pedi-
atric cardiac surgeons, rather than by cardiologists. How-
ever, given that most pediatric cardiologists will occasionally
be responsible for situations such as those previously noted,
it is important that they can provide appropriate care until
consultation with those more experienced in pediatric car-
diac intensive care can be obtained. In some cases the
pediatric cardiologist may be the only source of expertise
(e.g., in understanding the limitations of echocardiography
in delineating the anatomy/physiology of a hemodynami-
cally compromised postoperative patient). Hence, it is
important that the pediatric cardiologist be familiar with
critical care-related issues, often specific to a given cardiac
lesion, when providing consultation in the context of the
critically ill patient. Thus, core requirements apply to all
trainees seeking board certification in pediatric cardiology.
Advanced requirements, which are more comprehensive,
apply to practitioners who will undertake primary respon-
sibility for the comprehensive management of critically ill
pediatric patients with congenital or acquired heart disease.
These documents specify training guidelines in pediatric
cardiac critical care for pediatric cardiology trainees. The
advanced guidelines specify training requirements only for
practitioners who are board eligible/board certified in pedi-
atric cardiology. These guidelines do not address what
might be a suitable course of training for cardiac critical care
for practitioners with primary training in a discipline other
than pediatric cardiology.
CORE TRAINING: GOALS AND METHODS
General Requirements
At the end of the pediatric cardiology fellowship, the
board-eligible pediatric cardiologist should reliably be able
to do the following:
1) Evaluate and treat neonates and infants with critical
structural cardiac disease. Evaluation and treatment
includes:
a) Establishing an accurate anatomic diagnosis and ascer-
taining the relevant cardio-pulmonary physiology.
b) Providing appropriate medical therapy to stabilize
the patient (provide for adequate oxygen delivery and
organ perfusion).
c) Knowing what medical and surgical treatments are
appropriate for the condition and what the short-
and long-term outcomes of these therapies are.
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In particular, the trainee should have sufficient
training and experience to be efficient in managing
these patients:
● Neonates and infants with ductal-dependent left
and right-sided obstructive lesions.
● Neonates with d-transposition of the great arteries.
● Neonates with total anomalous pulmonary venous
connection with obstruction.
● Infants with anomalous origin of the left coronary
artery.
2) Evaluate and treat neonates, infants, and older patients
with other forms of critical cardiac disease.
In particular, the trainee should have sufficient train-
ing and experience to be efficient in evaluating and
treating these patients:
● Patients with primary myocardial dysfunction.
● Patients with acutely compromised cardiopulmonary
status due to myocarditis or cardiomyopathy (includ-
ing that due to rheumatic fever, Kawasaki disease,
and so on).
● Patients with acutely symptomatic arrhythmias.
● Patients with acutely compromised cardiopulmonary
status due to endocarditis.
● Patients with pericardial effusion.
● Patients having a hypercyanotic episode (“tet spell”).
● Neonates and infants with increased pulmonary vas-
cular resistance, with or without structural abnormal-
ity of the heart.
3) Provide care, or consultation for those providing pri-
mary care, for cardiac patients with illness of non-
cardiac origin.
For example, a cyanotic patient with respiratory
syncitial virus pneumonitis requires care somewhat dif-
ferent than a patient with a normal heart.
4) Provide consultation for those caring for postoperative
cardiac patients.
In particular, the pediatric cardiologist should be able
to do the following:
● Provide interpretation of diagnostic studies, such as
echocardiograms and heart catheterization, including
clearly delineating the limitations of such studies.
● Diagnose and treat acutely symptomatic arrhyth-
mias.
● Provide consultation regarding therapies to maxi-
mize oxygen delivery and cardiac output.
● Provide consultation regarding pharmacologic and
other therapies for patients with “single ventricle”
physiology.
● Provide consultation regarding therapy for patients
with increased pulmonary vascular resistance.
SPECIFIC AREAS OF KNOWLEDGE AND COMPETENCE
The following section lists certain areas of special impor-
tance.
1. Cardiopulmonary physiology, especially as it applies to
cardiac patients in the ICU setting.
a) Determinants of, and means of influencing, oxygen
delivery, cardiac output, and vascular resistance.
b) The physiology of the patient with a single ventricle,
including determinants of, and means of influenc-
ing, systemic arterial oxygen saturation, systemic
perfusion, and myocardial work.
c) The physiology of the patient with a ductal-dependent
left-sided obstructive lesion, including determinants
of, and means of influencing, systemic arterial oxy-
gen saturation, systemic perfusion, and myocardial
work.
d) The physiology of the patient with a fixed restriction
of pulmonary blood flow, including determinants of,
and means of influencing, systemic arterial oxygen
saturation, systemic perfusion, and myocardial work.
e) The physiology associated with d-transposition of
the great arteries.
f) The physiology of cardiopulmonary interaction, in-
cluding how mechanical ventilation affects cardiac
output.
2. Cardiovascular pharmacology.
The trainee should learn the actions, mechanisms of
action, side effects, and clinical use of:
a) Inotropic agents (e.g., digoxin, adrenergic agonists,
phosphodiesterase inhibitors).
b) Vasodilators/antihypertensive agents (e.g., alpha ad-
renergic antagonists, angiotensin-converting enzyme
inhibitors, calcium channel antagonists, beta adren-
ergic antagonists).
c) Commonly used antiarrhythmic drugs (e.g., digoxin,
procainamide, lidocaine, amiodarone).
d) Inhaled nitric oxide.
e) Prostaglandin E1.
f) Neuromuscular blocking agents (e.g., pancuronium,
succinylcholine).
g) Analgesics and sedatives (e.g., morphine, fentanyl,
ketamine, benzodiazepines).
h) Anticoagulants (unfractionated and low molecular
weight heparin, warfarin).
i) Diuretics (e.g., furosemide, chlorothiazide).
j) Prostacyclin and other pulmonary vasodilators.
3. The relationship between cardiac structure, function,
and clinical state.
The trainee should learn:
a) How cardiac structural abnormalities (e.g., obstruc-
tion of the atrial septum in hypoplastic left heart
syndrome) affect cardiopulmonary function, physiol-
ogy, and hence the clinical state of the patient.
b) Methods (e.g., echocardiography, invasive pressure
measurements, arterial blood gas analysis, magnetic
resonance imaging) to determine and measure car-
diac structure, function, and physiology in the ICU
patient, and the limitations of these techniques.
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c) Indications for remedy of structural lesions (in
both unoperated and operated patients), and ap-
propriate means of therapy (surgical, catheter-
based intervention).
4. Diagnosis and therapy of arrhythmias, especially those
occurring in ICU patients.
In particular, the trainee should be familiar with the
use of atrial and ventricular pacing leads or transesoph-
ageal electrocardiography for diagnosing and treating
arrhythmias, and the diagnosis and therapy of junc-
tional ectopic tachycardia.
5. Airway management skills.
6. Provision of analgesia and sedation.
7. Conduct of cardiopulmonary resuscitation.
8. Commonly used modes of mechanical ventilation and
their application in patients with heart disease.
9. Common complications that occur in cardiac patients
in the ICU, and how they may be prevented and
treated.
The trainee should be familiar with factors that
predispose to common postoperative complications
(e.g., catheter-related sepsis, pathological thrombo-
sis, surgically-induced heart block), appropriate di-
agnostic techniques, and therapy for these complica-
tions.
10. Familiarity with extracorporeal membrane oxygenation
and other cardiac support systems.
11. Indications for, and general principles, for providing
“end-of-life” or “palliative” care.
REQUIRED TRAINING PERIOD FOR CORE TRAINING
In training programs where pediatric cardiology fellows
provide primary care of pediatric cardiac patients in the ICU
(generally programs that have a separate cardiac ICU), a
minimum of two months’ full-time experience in the ICU is
recommended. For programs where pediatric cardiology
fellows act as consultants for cardiac patients in the intensive
care setting, at least four months’ experience providing such
consultation is recommended.
Trainees will be evaluated by the appropriate supervising
faculty, and both written and oral feedback will be provided
to the trainee. Written evaluations, addressing specific areas
of competence, will be developed at each training site.
ADVANCED TRAINING: GOALS AND METHODS
Advanced training in pediatric cardiac intensive care is in-
tended to prepare practitioners who will undertake primary
responsibility for the comprehensive management of critically
ill patients with congenital or acquired heart disease. Because
this discipline stands at the nexus of pediatric cardiology and
pediatric critical care, some physicians with primary training in
fields other than pediatric cardiology work in this area. This
document describes an appropriate advanced practitioner train-
ing program only for physicians board eligible or board
certified in pediatric cardiology; it does not specify what an
appropriate training program should be for those trained in
other disciplines (e.g., critical care medicine [CCM] or pedi-
atric anesthesiology).
GENERAL REQUIREMENTS
1. The advanced practitioner must be board certified/board
eligible in pediatric cardiology.
2. Advanced practitioners must have (at least) nine months
of clinical training beyond the core training as outlined
in the previous text. (This excludes practitioners doubly
boarded in pediatric cardiology and pediatric CCM.)
Practitioners with training in (only) pediatric cardiology
are therefore expected, in addition to having three years
of pediatric cardiology training, to have one month of
training in anesthesia, four months’ experience predom-
inantly in general pediatric CCM, and at least four
months’ experience caring for pediatric cardiac patients
in the ICU setting (a total of 9 months).
The practitioner must have sufficient experience in man-
aging term and pre-term neonates both preoperatively and
postoperatively.
SPECIFIC AREAS OF KNOWLEDGE AND COMPETENCE
Specific requirements for advanced training include all of
those for core training (listed in the previous text), as well as
the following:
1. Mechanical ventilation.
a) Indications for and utilization of commonly em-
ployed modes of mechanical ventilation, as well as
more advanced modes of ventilation (e.g., high-
frequency oscillatory ventilation).
b) Optimal ways of providing gas exchange for patients
with congenital heart disease, taking into account
factors such as the effect of airway pressure on
venous return, the impact of fiO2 on pulmonary
vascular resistance, arterial O2 saturation, and sys-
temic perfusion.
c) Pulmonary toxicity related to barotrauma, volu-
trauma, and high levels of inspired oxygen, and how
to minimize such toxicity.
2. Indications for, application of, and complications re-
lated to mechanical support for the failing cardiopul-
monary system. Current systems that provide such
support include extracorporeal life support, ventricular
support devices, and intra-aortic balloon pumps. Ex-
pertise in at least one form of mechanical support
should result from advanced-level training.
3. Performance of invasive procedures often required in
managing critically ill cardiac patients. These proce-
dures include advanced techniques for intravascular
access (e.g., subclavian vein and internal jugular venous
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cannulation), insertion of chest tubes, pericardiocente-
sis, and so on.
4. Utilization of more advanced cardiovascular pharmaco-
logic therapy (e.g., esmolol for therapy of hypertension,
vasopressin for therapy of hypotension).
5. Advanced skills in evaluation and treatment of arrhyth-
mias (e.g., utilization of epicardial electrodes and trans-
esophageal leads for diagnosis and treatment of rhythm
abnormalities, use of pharmacologic agents to treat
arrhythmias, and so on).
6. Advanced management of pulmonary hypertension.
7. Diagnosis and treatment of less frequently encountered/
more complex postoperative complications, including
lesion-specific complications. Such complications include
significant residual cardiac lesions, paralyzed hemi-
diaphragm(s), large airway obstruction, compartment syn-
drome following femoral arterial cannulation for cardio-
pulmonary bypass, prolonged chest tube drainage, and so
on. The practitioner should be familiar with indications
for invasive evaluation (e.g., heart catheterization or bron-
choscopy) and invasive therapy (e.g., additional cardiac
surgery, interventional catheterization, tracheostomy).
8. Evaluation and management of multisystem organ failure.
9. Postoperative management of orthotopic heart trans-
plant patients, and management of acute rejection.
10. Diagnosis and management of renal failure, including
indications for renal replacement therapy.
11. Diagnosis and management of forms of neurological
dysfunction, sometimes seen in patients with critical
heart disease (seizures, stroke, global ischemia, increased
intracranial pressure).
12. Available means of providing nutritional support, and
the most appropriate means for a given patient.
13. Transfusion management, and recognition and treat-
ment of common transfusion-related complications.
doi:10.1016/j.jacc.2005.07.019
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INTRODUCTION
The number of adults with congenital heart disease (CHD)
has increased significantly over the past 20 years. Palliative
surgery and, more recently, non-surgical and medical inter-
ventions have permitted even those with the most complex
lesions to reach adulthood. The recent Bethesda Conference
estimated that there are approximately 420,000 CHD
patients in the U.S., based on models that exclude simple
congenital lesions such as bicuspid aortic valve, small atrial
or ventricular septal defect, and mild pulmonary stenosis. Of
those patients, approximately three-fourths have lesions that
are moderately complex and one-fourth have lesions of great
complexity.
Establishing an adequate system for the care of these
individuals is a challenging task that can best be accom-
plished through an integrative approach that draws on the
skills and knowledge base of both pediatric and medical
(adult) cardiologists within an adult CHD center. Many
adults with CHD continue to be cared for by pediatric
cardiologists, who are well trained to deal with the often
complex problems associated with CHD, but are generally
unprepared to manage unique problems of adults with
CHD, including long-term complications and adult health
care issues such as pregnancy and overlay of acquired
disease. Thus, basic knowledge of issues unique to adults
with CHD as well as knowledge of the indications for
referral to a specialized adult CHD (ACHD) center is
required of all pediatric cardiologists.
The American College of Cardiology (ACC) has
published training guidelines for Adult Cardiovascular
Medicine Core Cardiology Training II (COCATS 2)
which include recommendations regarding care of adult
patients with CHD. These recommendations were de-
veloped with the recognition that appropriate training
and education for adult cardiologists is currently defi-
cient in CHD, but that eventually the numbers and
complexity of such adult patients will demand that many
be cared for in adult settings by cardiologists with an
internal medicine-adult cardiology background (1). It
will be at least a decade or more before the graduates
of adult cardiology training programs are sufficiently
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